PolyPurine Reverse Hoogsteen Hairpins Work as RNA Species for Gene Silencing
Aubets, Eva (Universitat de Barcelona)
Chillón Rodríguez, Miguel (Vall d'Hebron Institut de Recerca (VHIR))
Ciudad, Carlos J. (Universitat de Barcelona)
Noé, Véronique (Universitat de Barcelona)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	PolyPurine Reverse Hoogsteen Hairpins (PPRHs) are gene-silencing DNA-oligonucleotides developed in our laboratory that are formed by two antiparallel polypurine mirror repeat domains bound intramolecularly by Hoogsteen bonds. The aim of this work was to explore the feasibility of using viral vectors to deliver PPRHs as a gene therapy tool. After treatment with synthetic RNA, plasmid transfection, or viral infection targeting the survivin gene, viability was determined by the MTT assay, mRNA was determined by RT-qPCR, and protein levels were determined by Western blot. We showed that the RNA-PPRH induced a decrease in cell viability in a dose-dependent manner and an increase in apoptosis in PC-3 and HeLa cells. Both synthetic RNA-PPRH and RNA-PPRH intracellularly generated upon the transfection of a plasmid vector were able to reduce survivin mRNA and protein levels in PC-3 cells. An adenovirus type-5 vector encoding the PPRH against survivin was also able to decrease survivin mRNA and protein levels, leading to a reduction in HeLa cell viability. In this work, we demonstrated that PPRHs can also work as RNA species, either chemically synthesized, transcribed from a plasmid construct, or transcribed from viral vectors. Therefore, all these results are the proof of principle that viral vectors could be considered as a delivery system for PPRHs.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	PPRH ; Oligonucleotide ; Survivin ; Gene targeting ; Gene silencing ; Delivery ; Viral vectors ; Adenovirus ; Cancer therapy
Publicat a:	International journal of molecular sciences, Vol. 22 (september 2021) , ISSN 1422-0067

DOI: 10.3390/ijms221810025
PMID: 34576188

17 p, 3.2 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats